Emilia Loch

Emilia Loch

Auto-generated profile, based on publicly available information

Emilia Loch

Zagłębie Oncology Center in Dąbrowa Górnicza, 13 Szpitalna Street, Dąbrowa Górnicza, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PMPaulina Mikulec
Paulina Mikulec
KKKamil Kerknawi
Kamil Kerknawi
ELEmilia Loch
Emilia Loch
MZMichalina Zagalska
Michalina Zagalska
MTMarta Turek
Marta Turek
Introduction: Type 2 Diabetes Mellitus (T2DM) is a major global health burden, marked by chronic hyperglycemia and complications. Physical activity is central to management, with High-Intensity Interval Training (HIIT) emerging as a time-efficient, evidence-based approach. This review examines HIIT’s impact on glycemic control, cardiorespiratory fitness, body composition, and inflammation, also addressing safety and feasibility. Methods: A narrative review was conducted via PubMed using terms such as”Type 2 Diabetes, "“glycemia, "“HbA1c, "“physical activity, " and”HIIT." From forty articles screened, nineteen met inclusion criteria. Results and Discussion: HIIT effectively improves T2DM outcomes. It lowers HbA1c, fasting and postprandial glucose, and enhances insulin sensitivity and beta-cell function. Compared to moderate-intensity continuous training (MICT), HIIT often yields superior VO₂max improvements. It also reduces BMI, total and visceral fat, and improves lipid profiles. HIIT is associated with lower inflammatory markers. Implementation is feasible and safe, even for older adults, with high adherence and minimal adverse events. Conclusion: HIIT is a potent non-pharmacological tool in T2DM management, offering benefits across metabolic and cardiovascular domains. Its ability to improve glycemic control, fitness, body composition, and inflammation underscores its clinical relevance. Current evidence supports integrating HIIT into standard care for T2DM patients.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
ABAleksandra Białas
Aleksandra Białas
WLWeronika Lusarczyk
Weronika Lusarczyk
NSNatalia Sapeda
Natalia Sapeda
AMAleksandra Młocek
Aleksandra Młocek
ATAdrianna Truszyńska-Zawisza
Adrianna Truszyńska-Zawisza
ELEmilia Loch
Emilia Loch
Premenstrual Syndrome (PMS) and its severe form, Premenstrual Dysphoric Disorder (PMDD), are prevalent cyclical disorders affecting the emotional, behavioral, and physical well-being of women of reproductive age. This review aims to present an overview of the current understanding of PMS/PMDD and critically examine both pharmacological and non-pharmacological treatment methods. Based on recent clinical trials and systematic reviews, selective serotonin reuptake inhibitors (SSRIs), hormonal therapies, and emerging drugs like sepranolone and ulipristal acetate demonstrate efficacy in symptom reduction (Bäckström et al., 2021; Comasco et al., 2020; Maranho et al., 2023). Simultaneously, cognitive-behavioral therapy (CBT), mindfulness-based interventions, nutritional supplements, herbal medicine, and even open-label placebos are gaining attention as effective non-pharmacological alternatives (Frey Nascimento et al., 2025; Reilly et al., 2023; Shojiasi et al., 2024; Sultana et al., 2022). Despite promising findings, further high-quality research is needed to tailor personalized and integrative treatment strategies.